Chona Ray, N.P.
Hematology & Oncology Physician in Long Beach, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Chona Ray, N.P. reported a CMS MIPS final score of 99.1/100 - above the 83.5 national average - and filed 1,036 Medicare Part D claims in 2024.
- 99.1/100
- MIPS score · +16 vs avg
- 1K
- Part D claims, 2024
- 73%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Chona Ray, N.P.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1932128402), first enumerated 07/18/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,036 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 99.1/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- State context
State board disciplinary context
California statewide board action statistics are published annually — these figures describe aggregate state activity, not Chona Ray, N.P.'s individual license status. Verify directly with the state medical board.
Source: MBC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1932128402 · Hematology & Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-ELITE · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1932128402
- ENUM-LEGACY 2006
- TAX-MID 12K Hematology &
- MIPS-ELITE 99.1/100
- RX-MID 1,036
- BOOK-LIGHT 1,306 in California
- PHOTO-FINISH Shukaib Arslan · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Ray · this provi…
Ray · this provider
99.1 MIPS pts
- Shukaib Arslan ·…
Shukaib Arslan
99.1 MIPS pts
- Jyoti Malhotra ·…
Jyoti Malhotra
99.1 MIPS pts
- Carol Tweed · near
Carol Tweed
99.1 MIPS pts
- Ali Ameri · high…
Ali Ameri
99.2 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Chona Ray, N.P.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
99 ≥ 91st percentile 91% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Chona Ray, N.P. sits
This provider among hematology & oncology physician peers
Across the 4,019 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Chona Ray, N.P. writes more Part D claims than 65% of them and scores higher on MIPS quality than 87% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Chona Ray, N.P.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Chona Ray, N.P. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Chona Ray, N.P.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in California
How Hematology & Oncology Physician compares to other specialties among California providers
Hematology & Oncology Physician ranks #80 among California's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the California provider total, by primary NUCC taxonomy. The highlighted bar is Hematology & Oncology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Chona Ray, N.P.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 99.1/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Specialty volume Hematology & Oncology Physician US NPIs
99.1/100 MIPS final score - 15.6 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Hematology & Oncology Physician. Quality dim: 85.2.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1932128402 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | N.P. |
| Gender | Female |
| NPI Issued | 07/18/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Chona Ray, N.P.'s current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1932128402 is the unique 10-digit identifier CMS uses to link Ray across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Chona Ray, N.P. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Chona Ray, N.P.. To verify Chona Ray, N.P.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
27% brand-name claims vs 73% generic, on 1,036 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 1,453.7
- Total Day Supply
- 39,375
- Brand vs Generic
- 27% brand / 73% generic
- Brand Drug Cost
- $1.6M
- Generic Drug Cost
- $40K
- Opioid Claims
- 113 (10.9% rate)
- Antibiotic Claims
- 75
Patient Demographics
- Average Patient Age
- 74.3 years
- Avg HCC Risk Score
- 3.05
- Gender Split
- 55% female / 45% male
- Age Distribution
- <65: 14, 65-74: 61, 75-84: 45, 85+: 16
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Chona Ray, N.P. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Eliquis
Eliquis
91 claims
- Levothyroxine Sodium
Levothyroxine Sodium
59 claims
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
50 claims
- Revlimid 32
Revlimid
32 claims
- Allopurinol 31
Allopurinol
31 claims
- Potassium Chloride 29
Potassium Chloride
29 claims
- Prednisone 29
Prednisone
29 claims
- Abiraterone Acetate 27
Abiraterone Acetate
27 claims
| Drug | Claims |
|---|---|
| Eliquis Apixaban | 91 |
| Levothyroxine Sodium | 59 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 50 |
| Revlimid Lenalidomide | 32 |
| Allopurinol | 31 |
| Potassium Chloride | 29 |
| Prednisone | 29 |
| Abiraterone Acetate | 27 |
| Warfarin Sodium | 26 |
| Ondansetron Hcl | 23 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Chona Ray, N.P. fits within the Hematology & Oncology Physician landscape nationally.
Chona Ray, N.P.'s 1,036 claims are above the specialty average of 885.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Ray, both outside California so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (99.1 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Ray.
One of 1,306 Hematology & Oncology Physician providers enrolled in California, 5 are shown here.
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Chona Ray, N.P.'s specialty? ▼
How much does Chona Ray, N.P. prescribe under Medicare Part D? ▼
What is Chona Ray, N.P.'s Medicare quality score? ▼
Where is Chona Ray, N.P. located? ▼
What is Chona Ray, N.P.'s NPI number? ▼
Does Chona Ray, N.P. prescribe more brand-name or generic drugs? ▼
Does Chona Ray, N.P. prescribe opioids? ▼
How many Hematology & Oncology Physician providers are there in the US? ▼
What drugs does Chona Ray, N.P. prescribe most often? ▼
Does Chona Ray, N.P. accept Medicare? ▼
How can I verify Chona Ray, N.P.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.